These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 28296249)

  • 1. Association between non-invasively diagnosed hepatic steatosis and chronic kidney disease in Chinese adults on their health check-up.
    Zeng J; Sun C; Sun WL; Chen GY; Pan Q; Yan SY; Xu ZJ; Chen YW; Fan JG
    J Dig Dis; 2017 Apr; 18(4):229-236. PubMed ID: 28296249
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The fatty liver index as a predictor of incident chronic kidney disease in a 10-year prospective cohort study.
    Huh JH; Kim JY; Choi E; Kim JS; Chang Y; Sung KC
    PLoS One; 2017; 12(7):e0180951. PubMed ID: 28738057
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between PNPLA3rs738409 polymorphism decreased kidney function in postmenopausal type 2 diabetic women with or without non-alcoholic fatty liver disease.
    Mantovani A; Zusi C; Sani E; Colecchia A; Lippi G; Zaza GL; Valenti L; Byrne CD; Maffeis C; Bonora E; Targher G
    Diabetes Metab; 2019 Oct; 45(5):480-487. PubMed ID: 30763699
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of chronic kidney disease in patients with non-alcoholic fatty liver disease: A cohort study.
    Sinn DH; Kang D; Jang HR; Gu S; Cho SJ; Paik SW; Ryu S; Chang Y; Lazo M; Guallar E; Cho J; Gwak GY
    J Hepatol; 2017 Dec; 67(6):1274-1280. PubMed ID: 28870674
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The correlation between fatty liver disease and chronic kidney disease.
    Chen PC; Kao WY; Cheng YL; Wang YJ; Hou MC; Wu JC; Su CW
    J Formos Med Assoc; 2020 Jan; 119(1 Pt 1):42-50. PubMed ID: 30876789
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-alcoholic fatty liver disease and clinical outcomes in chronic kidney disease.
    Chinnadurai R; Ritchie J; Green D; Kalra PA
    Nephrol Dial Transplant; 2019 Mar; 34(3):449-457. PubMed ID: 29390103
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between Controlled Attenuation Parameter and Hepatic Steatosis as Assessed by Ultrasound in Alcoholic or Nonalcoholic Fatty Liver Disease.
    Ahn JM; Paik YH; Min SY; Cho JY; Sohn W; Sinn DH; Gwak GY; Choi MS; Lee JH; Koh KC; Paik SW; Yoo BC
    Gut Liver; 2016 Mar; 10(2):295-302. PubMed ID: 26347511
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of non-alcoholic fatty liver disease among patients with non-diabetic chronic kidney disease detected by transient elastography.
    Behairy MA; Sherief AF; Hussein HA
    Int Urol Nephrol; 2021 Dec; 53(12):2593-2601. PubMed ID: 33675475
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intrahepatic triglyceride content is independently associated with chronic kidney disease in obese adults: A cross-sectional study.
    Pan LL; Zhang HJ; Huang ZF; Sun Q; Chen Z; Li ZB; Yang SY; Li XY; Li XJ
    Metabolism; 2015 Sep; 64(9):1077-85. PubMed ID: 26144271
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FIB-4 Index and Diabetes Mellitus Are Associated with Chronic Kidney Disease in Japanese Patients with Non-Alcoholic Fatty Liver Disease.
    Seko Y; Yano K; Takahashi A; Okishio S; Kataoka S; Okuda K; Mizuno N; Takemura M; Taketani H; Umemura A; Nishikawa T; Yamaguchi K; Moriguchi M; Okanoue T; Itoh Y
    Int J Mol Sci; 2019 Dec; 21(1):. PubMed ID: 31881781
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Noninvasive fibrosis markers and chronic kidney disease among adults with nonalcoholic fatty liver in USA.
    Wijarnpreecha K; Thongprayoon C; Scribani M; Ungprasert P; Cheungpasitporn W
    Eur J Gastroenterol Hepatol; 2018 Apr; 30(4):404-410. PubMed ID: 29215435
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nonalcoholic fatty liver disease is independently associated with an increased incidence of chronic kidney disease in patients with type 1 diabetes.
    Targher G; Mantovani A; Pichiri I; Mingolla L; Cavalieri V; Mantovani W; Pancheri S; Trombetta M; Zoppini G; Chonchol M; Byrne CD; Bonora E
    Diabetes Care; 2014 Jun; 37(6):1729-36. PubMed ID: 24696459
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nonalcoholic fatty liver disease accelerates kidney function decline in patients with chronic kidney disease: a cohort study.
    Jang HR; Kang D; Sinn DH; Gu S; Cho SJ; Lee JE; Huh W; Paik SW; Ryu S; Chang Y; Shafi T; Lazo M; Guallar E; Cho J; Gwak GY
    Sci Rep; 2018 Mar; 8(1):4718. PubMed ID: 29549269
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High FIB-4 index as an independent risk factor of prevalent chronic kidney disease in patients with nonalcoholic fatty liver disease.
    Xu HW; Hsu YC; Chang CH; Wei KL; Lin CL
    Hepatol Int; 2016 Mar; 10(2):340-6. PubMed ID: 26676626
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic kidney disease and nonalcoholic Fatty liver disease proven by transient elastography.
    Mikolasevic I; Racki S; Bubic I; Jelic I; Stimac D; Orlic L
    Kidney Blood Press Res; 2013; 37(4-5):305-10. PubMed ID: 24029696
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fatty liver index, albuminuria and the association with chronic kidney disease: a population-based study in China.
    Sun K; Lin D; Li F; Qi Y; Feng W; Yan L; Chen C; Ren M; Liu D
    BMJ Open; 2018 Jan; 8(1):e019097. PubMed ID: 29382678
    [TBL] [Abstract][Full Text] [Related]  

  • 17. US-FLI score - Is it possible to predict the steatosis grade with an ultrasonographic score?
    Xavier SA; Monteiro SO; Arieira CM; Castro FD; Magalhães JT; Leite SM; Marinho CM; Cotter JB
    Mol Genet Metab; 2021 Mar; 132(3):204-209. PubMed ID: 33558081
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MAFLD and risk of CKD.
    Sun DQ; Jin Y; Wang TY; Zheng KI; Rios RS; Zhang HY; Targher G; Byrne CD; Yuan WJ; Zheng MH
    Metabolism; 2021 Feb; 115():154433. PubMed ID: 33212070
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between fatty liver index and risk of end-stage renal disease stratified by kidney function in patients with type 2 diabetes: A nationwide population-based study.
    Chung GE; Han K; Lee KN; Bae JH; Yang SY; Choi SY; Yim JY; Heo NJ
    Diabetes Metab; 2023 Jul; 49(4):101454. PubMed ID: 37244418
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased Risk for Cardiovascular Events in Patients with Diabetic Kidney Disease and Non-Alcoholic Fatty Liver Disease.
    Chinnadurai R; Chrysochou C; Kalra PA
    Nephron; 2019; 141(1):24-30. PubMed ID: 30384370
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.